Search

Your search keyword '"Takeda, Asami"' showing total 461 results

Search Constraints

Start Over You searched for: Author "Takeda, Asami" Remove constraint Author: "Takeda, Asami"
461 results on '"Takeda, Asami"'

Search Results

6. Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS)

8. Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study

10. Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis

11. Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study

14. Utility of glomerular Gd-IgA1 staining for indistinguishable cases of IgA nephropathy or Alport syndrome

16. Unfolding impacts of the COVID-19 pandemic on micro, small, and medium-sized enterprises in Asia.

17. Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS)

18. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS)

19. Rationale and design of the Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study.

23. Association between Serum 25-Hydroxyvitamin D Levels and Sarcopenia in Patients Undergoing Chronic Haemodialysis.

24. Impact of an angulated aorto-septal relationship on cardio-cerebrovascular outcomes in patients undergoing hemodialysis.

25. Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study

31. Optimal dose of rituximab in ABO‐incompatible kidney transplantation in patients with low anti‐A/B antibody titers: A single‐center retrospective cohort study

33. Short-term outcomes of second kidney transplantation compared with those of first transplantation in Japanese patients: a single-center, retrospective, observational study

35. Acute Kidney Injury and Remission of Proteinuria in Minimal Change Disease

38. Clinical, Pathological, and Genetic Characteristics in Patients with Focal Segmental Glomerulosclerosis

39. Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial

42. Initiation of Renin-Angiotensin System Inhibitors and the Incidence of First Complete Remission in Patients with Primary Nephrotic Syndrome: A Nationwide Cohort Study

43. Medullary Cystic Kidney Disease and Focal Segmental Glomerulosclerosis Caused by a Compound Heterozygous Mutation in TTC21B

44. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

45. Extended-Release Tacrolimus and mTOR Inhibitor-Based Immunosuppressive Regimen in Living Donor Kidney Transplantation: A Single-Center Retrospective Cohort Study

46. Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis

48. How to estimate kidney function in kidney transplant recipients with mild to moderate kidney impairment: comparison of estimated glomerular filtration (eGFR) values between creatinine-based GFR equations and cystatin C-based GFR equations for Japanese population

50. Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial

Catalog

Books, media, physical & digital resources